Cargando…

Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly

DNA vaccination has tremendous potential for treating or preventing numerous diseases for which traditional vaccines are ineffective but the technique can be limited by low immunogenicity. Current synthetic DNA delivery systems are versatile and safe, but substantially less efficient than viruses. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xianfeng, Liu, Bin, Yu, Xianghui, Zha, Xiao, Zhang, Xizhen, Wang, Xueyun, Chen, Yu, Chen, Yan, Chen, Yue, Shan, Yaming, Jin, Yinghua, Wu, Yongge, Liu, Junqiu, Kong, Wei, Shen, Jiacong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124441/
https://www.ncbi.nlm.nih.gov/pubmed/17686512
http://dx.doi.org/10.1016/j.biomaterials.2007.07.002
_version_ 1783515831530946560
author Zhou, Xianfeng
Liu, Bin
Yu, Xianghui
Zha, Xiao
Zhang, Xizhen
Wang, Xueyun
Chen, Yu
Chen, Yan
Chen, Yue
Shan, Yaming
Jin, Yinghua
Wu, Yongge
Liu, Junqiu
Kong, Wei
Shen, Jiacong
author_facet Zhou, Xianfeng
Liu, Bin
Yu, Xianghui
Zha, Xiao
Zhang, Xizhen
Wang, Xueyun
Chen, Yu
Chen, Yan
Chen, Yue
Shan, Yaming
Jin, Yinghua
Wu, Yongge
Liu, Junqiu
Kong, Wei
Shen, Jiacong
author_sort Zhou, Xianfeng
collection PubMed
description DNA vaccination has tremendous potential for treating or preventing numerous diseases for which traditional vaccines are ineffective but the technique can be limited by low immunogenicity. Current synthetic DNA delivery systems are versatile and safe, but substantially less efficient than viruses. Here, a novel multicomponent supramolecular system involving the preparation of mannose-bearing chitosan oligomers microspheres with entrapping complexes of DNA vaccine and polyethylenimine was developed to mimic many of the beneficial properties of the viruses. After delivery by intramuscular immunization in BALB/c mice, the microspheres induced an enhanced serum antibody responses two orders of magnitude greater than naked DNA vaccine. Additionally, in contrast to naked DNA, the microspheres induced potent cytotoxic T lymphocyte responses at a low dose. Consequently, formulation of DNA vaccines into multicomponent vectors is a powerful means of increasing vaccine potency.
format Online
Article
Text
id pubmed-7124441
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71244412020-04-08 Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly Zhou, Xianfeng Liu, Bin Yu, Xianghui Zha, Xiao Zhang, Xizhen Wang, Xueyun Chen, Yu Chen, Yan Chen, Yue Shan, Yaming Jin, Yinghua Wu, Yongge Liu, Junqiu Kong, Wei Shen, Jiacong Biomaterials Article DNA vaccination has tremendous potential for treating or preventing numerous diseases for which traditional vaccines are ineffective but the technique can be limited by low immunogenicity. Current synthetic DNA delivery systems are versatile and safe, but substantially less efficient than viruses. Here, a novel multicomponent supramolecular system involving the preparation of mannose-bearing chitosan oligomers microspheres with entrapping complexes of DNA vaccine and polyethylenimine was developed to mimic many of the beneficial properties of the viruses. After delivery by intramuscular immunization in BALB/c mice, the microspheres induced an enhanced serum antibody responses two orders of magnitude greater than naked DNA vaccine. Additionally, in contrast to naked DNA, the microspheres induced potent cytotoxic T lymphocyte responses at a low dose. Consequently, formulation of DNA vaccines into multicomponent vectors is a powerful means of increasing vaccine potency. Elsevier Ltd. 2007-11 2007-08-07 /pmc/articles/PMC7124441/ /pubmed/17686512 http://dx.doi.org/10.1016/j.biomaterials.2007.07.002 Text en Copyright © 2007 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zhou, Xianfeng
Liu, Bin
Yu, Xianghui
Zha, Xiao
Zhang, Xizhen
Wang, Xueyun
Chen, Yu
Chen, Yan
Chen, Yue
Shan, Yaming
Jin, Yinghua
Wu, Yongge
Liu, Junqiu
Kong, Wei
Shen, Jiacong
Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly
title Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly
title_full Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly
title_fullStr Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly
title_full_unstemmed Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly
title_short Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly
title_sort enhance immune response to dna vaccine based on a novel multicomponent supramolecular assembly
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124441/
https://www.ncbi.nlm.nih.gov/pubmed/17686512
http://dx.doi.org/10.1016/j.biomaterials.2007.07.002
work_keys_str_mv AT zhouxianfeng enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT liubin enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT yuxianghui enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT zhaxiao enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT zhangxizhen enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT wangxueyun enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT chenyu enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT chenyan enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT chenyue enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT shanyaming enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT jinyinghua enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT wuyongge enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT liujunqiu enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT kongwei enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly
AT shenjiacong enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly